Perrigo Co. (PRGO)
-NasdaqGS 119.48 
0.33(0.28%) May 17, 4:00PM EDT|After Hours
:
119.48 0.00 (0.00%) May 17, 4:32PM EDT
| Prev Close: | 119.81 |
|---|
| Open: | 120.30 |
|---|
| Bid: | 104.30 x 100 |
|---|
| Ask: | 120.89 x 200 |
|---|
| 1y Target Est: | 126.57 |
|---|
| Beta: | 0.19 |
|---|
| Next Earnings Date: | 12-Aug-13 |
|---|
| Day's Range: | 119.22 - 120.74 |
|---|
| 52wk Range: | 98.79 - 121.33 |
|---|
| Volume: | 493,749 |
|---|
| Avg Vol (3m): | 515,413 |
|---|
| Market Cap: | 11.24B |
|---|
| P/E (ttm): | 25.69 |
|---|
| EPS (ttm): | 4.65 |
|---|
| Div & Yield: | 0.36 (0.30%) |
|---|
The broker you select will become the default broker for Trade Now
Quotes delayed, except where indicated otherwise. Currency in USD.
Headlines
- The New Generic-Drug Battle Frontat Motley Fool(Sat, May 18)
- Good News For Health Care Stocks Part 2at Motley Fool(Fri, May 17)
- PERRIGO CO Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and ExhibitsEDGAR Online(Thu, May 16)
- Perrigo Stock Hits New 52-Week High (PRGO)at TheStreet(Wed, May 15)
- Perrigo Launches First-Ever Industry Marketing Campaign For Store Brand OTC MedicationsPR Newswire(Mon, May 13)
- These 4 Stocks Saw Trading Price Swings This Past Week Post Earningsat Wall St. Cheat Sheet(Sat, May 11)
- PERRIGO CO FinancialsEDGAR Online Financials(Sat, May 11)
- Perrigo Becomes #16 Most Shorted Nasdaq 100 Component, Replacing Intuitat TheStreet(Fri, May 10)
- Cramer Says Sell Teva Pharmaceutical, But Buy SunTrust Banks and These 2 Stocksat Wall St. Cheat Sheet(Fri, May 10)
- Cramer's Top Stock Picks: PRGO OPEN YELP GRPNat TheStreet(Fri, May 10)
- PERRIGO CO Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and ExhibitsEDGAR Online(Fri, May 10)
- Cramer's 'Mad Money' Recap: Looking for Real Leadersat TheStreet(Thu, May 9)
- [video] Perrigo CEO: Mucinex Product Will Be a Big Winnerat CNBC(Thu, May 9)
- Cramer's Trend Watch: Store Brand Drugsat CNBC(Thu, May 9)
- Perrigo Company Earnings Call Nuggets: Consumer Business and Cash Prioritiesat Wall St. Cheat Sheet(Thu, May 9)
Key Statistics
| Forward P/E (1 yr): | 18.08 |
|---|
| P/S (ttm): | 3.31 |
|---|
| Ex-Dividend Date: | 29-May-13 |
|---|
Analysts
| Annual EPS Est
(Jun-13)
: | 5.62 |
|---|
| Quarterly EPS Est
(Jun-13)
: | 1.57 |
|---|
| Mean Recommendation*: | 2.2 |
|---|
| PEG Ratio (5 yr expected): | 1.81 |
|---|
Business Summary
Perrigo Company, through its subsidiaries, develops, manufactures, and distributes over-the-counter (OTC) and generic prescription (Rx) pharmaceuticals, infant formulas, nutritional products, and active pharmaceutical ingredients (API) worldwide.
View More